title: PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
authors.affiliation: Department of Medicine, Baylor University Medical Center, Dallas, TX, USA. dra@dermcenter.us
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
authors.forename: Marcial
authors.initials: M
authors.lastname: Oquendo
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Vincent
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004224:Diterpenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D005782:Gels; D006801:Humans; D055623:Keratosis, Actinic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: C486592:3-ingenyl angelate; D003879:Dermatologic Agents; D004224:Diterpenes; D005782:Gels